MX9805158A - Adn que codifica una proteina activadora de plasminogeno. - Google Patents
Adn que codifica una proteina activadora de plasminogeno.Info
- Publication number
- MX9805158A MX9805158A MX9805158A MX9805158A MX9805158A MX 9805158 A MX9805158 A MX 9805158A MX 9805158 A MX9805158 A MX 9805158A MX 9805158 A MX9805158 A MX 9805158A MX 9805158 A MX9805158 A MX 9805158A
- Authority
- MX
- Mexico
- Prior art keywords
- dna encoding
- plasminogen activating
- activating protein
- present
- vaccines
- Prior art date
Links
- 102000013566 Plasminogen Human genes 0.000 title abstract 2
- 108010051456 Plasminogen Proteins 0.000 title abstract 2
- 230000003213 activating effect Effects 0.000 title abstract 2
- 102000004169 proteins and genes Human genes 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 3
- 241000124008 Mammalia Species 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000004396 mastitis Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- C07K14/3153—Streptokinase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Endocrinology (AREA)
- Communicable Diseases (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Reproductive Health (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
La presente invencion proporciona moléculas de polinucleotidos que comprenden secuencias de nucleotidos que codifican proteínas activadoras de plasminogeno (PauA) de Streptococcus uberis, y polipéptidos sustancialmente homologos, fragmentos peptídicos y proteínas de fusion de las mismas; la presente invencion además proporciona composiciones y procedimientos para expresar de forma recombinante las proteínas PauA, los polipéptidos sustancialmente homologos, los fragmentos peptídicos y las proteínas de fusion codificadas por las moléculas de polinucleotidos de la presente invencion; la presente invencion proporciona además una vacuna para proteger a un miembro de una especie de mamífero contra la mastitis, que comprende una proteína PauA, un polipéptido sustancialmente homologo, un fragmento peptídico, una proteína de fusion, o una molécula de polinucleotido de la presente invencion.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5056597P | 1997-06-23 | 1997-06-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9805158A true MX9805158A (es) | 1998-12-31 |
Family
ID=21965988
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9805158A MX9805158A (es) | 1997-06-23 | 1998-06-23 | Adn que codifica una proteina activadora de plasminogeno. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6485904B1 (es) |
| EP (1) | EP0887410A3 (es) |
| JP (2) | JP3577219B2 (es) |
| CN (2) | CN1155708C (es) |
| AR (1) | AR015393A1 (es) |
| AU (1) | AU741724B2 (es) |
| BR (1) | BR9802198A (es) |
| CA (1) | CA2235471C (es) |
| HK (1) | HK1018479A1 (es) |
| MX (1) | MX9805158A (es) |
| NZ (1) | NZ330767A (es) |
| TW (1) | TWI225518B (es) |
| ZA (1) | ZA985414B (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1294771B1 (en) | 2000-06-12 | 2008-10-29 | University Of Saskatchewan | Chimeric GapC protein from Streptococcus and its use in vaccination and diagnosis |
| US6866855B2 (en) | 2000-06-12 | 2005-03-15 | University Of Saskatchewan | Immunization of dairy cattle with GapC protein against Streptococcus infection |
| US6833134B2 (en) | 2000-06-12 | 2004-12-21 | University Of Saskacthewan | Immunization of dairy cattle with GapC protein against Streptococcus infection |
| CN106520951A (zh) * | 2016-11-16 | 2017-03-22 | 广东海大畜牧兽医研究院有限公司 | 一种乳房链球菌pauA基因的特异性PCR检测方法 |
| BR112023017749A2 (pt) * | 2021-03-04 | 2023-10-03 | Helix Nanotechnologies Inc | Composições incluindo adjuvantes sbi e métodos de uso das mesmas |
| CN114736948B (zh) * | 2022-06-10 | 2022-11-08 | 深圳市帝迈生物技术有限公司 | 一种α2-抗纤溶酶活性测定试剂盒 |
| CN115116559B (zh) * | 2022-06-21 | 2023-04-18 | 北京百度网讯科技有限公司 | 氨基酸中原子坐标的确定及训练方法、装置、设备和介质 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5198214A (en) | 1983-08-31 | 1993-03-30 | Stolle Research & Development Corporation | Anti-mastitis polyvalent vaccine, method of administration and method for production thereof |
| GB8904762D0 (en) * | 1989-03-02 | 1989-04-12 | Glaxo Group Ltd | Biological process |
| US5648241A (en) * | 1989-09-15 | 1997-07-15 | The General Hospital Corporation | Conjugate vaccine against group B streptococcus |
| US5234684A (en) | 1989-10-24 | 1993-08-10 | Ciba-Geigy Corporation | Method for the prevention and treatment of bovine mastitis |
| GB9201013D0 (en) * | 1992-01-17 | 1992-03-11 | Animal Health Inst | Vaccines |
-
1998
- 1998-05-13 US US09/078,091 patent/US6485904B1/en not_active Expired - Fee Related
- 1998-06-17 EP EP98304759A patent/EP0887410A3/en not_active Withdrawn
- 1998-06-19 CA CA002235471A patent/CA2235471C/en not_active Expired - Fee Related
- 1998-06-22 TW TW087110021A patent/TWI225518B/zh active
- 1998-06-22 NZ NZ330767A patent/NZ330767A/en unknown
- 1998-06-22 CN CNB981033369A patent/CN1155708C/zh not_active Expired - Fee Related
- 1998-06-22 ZA ZA9805414A patent/ZA985414B/xx unknown
- 1998-06-22 AR ARP980102994A patent/AR015393A1/es not_active Application Discontinuation
- 1998-06-22 CN CNA2004100385551A patent/CN1552856A/zh active Pending
- 1998-06-22 AU AU73100/98A patent/AU741724B2/en not_active Ceased
- 1998-06-23 BR BR9802198A patent/BR9802198A/pt not_active Application Discontinuation
- 1998-06-23 MX MX9805158A patent/MX9805158A/es unknown
- 1998-06-23 JP JP19246698A patent/JP3577219B2/ja not_active Expired - Fee Related
-
1999
- 1999-08-05 HK HK99103391A patent/HK1018479A1/xx not_active IP Right Cessation
-
2003
- 2003-05-19 JP JP2003140706A patent/JP2004073180A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU7310098A (en) | 1998-12-24 |
| CA2235471C (en) | 2004-03-30 |
| JP3577219B2 (ja) | 2004-10-13 |
| AU741724B2 (en) | 2001-12-06 |
| CA2235471A1 (en) | 1998-12-23 |
| US6485904B1 (en) | 2002-11-26 |
| AR015393A1 (es) | 2001-05-02 |
| ZA985414B (en) | 1999-12-22 |
| NZ330767A (en) | 2000-02-28 |
| HK1018479A1 (en) | 1999-12-24 |
| CN1209455A (zh) | 1999-03-03 |
| CN1552856A (zh) | 2004-12-08 |
| BR9802198A (pt) | 1999-05-25 |
| CN1155708C (zh) | 2004-06-30 |
| TWI225518B (en) | 2004-12-21 |
| JPH11103869A (ja) | 1999-04-20 |
| JP2004073180A (ja) | 2004-03-11 |
| EP0887410A2 (en) | 1998-12-30 |
| EP0887410A3 (en) | 2000-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2001083782A3 (en) | Novel proteases | |
| EA200100565A1 (ru) | Новые стрептококковые антигены | |
| NZ591415A (en) | Haemophilus influenzae type B | |
| HUP0302965A2 (hu) | Vakcina | |
| BR9713463A (pt) | Fitase de bacillus subtilis, gene codificando a referida fitase, método para a produção e uso da mesma | |
| WO2002000860A3 (en) | Novel proteases | |
| EP0837131A3 (en) | Staphylococcus fibronectin binding protein compounds | |
| DE60033138D1 (de) | Polypeptide mit galaktoseoxidaseaktivität und dafür kodierende nukleisäuren | |
| MXPA03001984A (es) | Variantes de factor vii de coagulacion humano. | |
| AU6160201A (en) | Human polypeptides causing or leading to the killing of cells including lymphoidtumor cells | |
| DE69840230D1 (de) | Polypeptide mit prolyldipeptidylaminopeptidase-aktivität und dafür kodierende nukleinsäuren | |
| DK0750672T3 (da) | DNA-sekvenser for matrix-metalproteaser, deres tilvejebringelse og anvendelse | |
| EP0232523A3 (en) | Dna sequences which encode for proteins with the biological activity of husi-type i inhibitors, their production by gene technology and drugs containing these proteins | |
| MX9805158A (es) | Adn que codifica una proteina activadora de plasminogeno. | |
| DE69834194D1 (de) | Oberfläche-exponierte proteine von chlamydia pneumoniae | |
| EP1613345A4 (en) | COMPOSITIONS AND METHODS WITH THE RESPIRATORY SYNCYTIAL VIRUS SUB-GROUP B STAMM 9320 | |
| PT1141305E (pt) | Gene quimerico formado pelas sequencias de adn que codifica os determinantes antigenicos de quatro proteinas de l. infantum | |
| DE69734644D1 (de) | Carboxypeptidasen aus aspergillus oryzae und diese kodierende nukleinsäuren | |
| EP0843016A3 (en) | Staphylococcus FabD (malonylCoA:ACP transacylase) protein | |
| ATE278011T1 (de) | Human dnase ii | |
| ATE380823T1 (de) | Rekombinante adhesin-proteine aus haemophilus influenzae | |
| WO1999055885A3 (en) | Novel serine protease capable of selective cleavage of insulin-like growth factor binding protein | |
| MXPA05009954A (es) | Familia de proteinas secretadas. | |
| DE69033553T2 (de) | Rekombinante herstellung von laktoperoxidase | |
| BR0012740A (pt) | Compostos para tratamento de distúrbios do sistema infeccioso e imune e métodos para seu emprego |